Skip to content

To explore the molecular mechanism of electroacupuncture in improving postoperative cognitive dysfunction via regulating Th17/Treg immune axis

To explore the molecular mechanism of electroacupuncture in improving postoperative cognitive dysfunction via regulating Th17/Treg immune axis - Investigating the molecular mechanism of electroacupuncture in improving postoperative cognitive dysfunction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093820
Enrollment
Unknown
Registered
2024-12-12
Start date
2024-01-03
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Electroacupuncture group:Electroacupuncture stimulation was performed at acupuncture points.
Sham electroacupuncture group:Sham electroacupuncture stimulation was performed at the acupuncture points.

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Elderly patients aged between 65 and 80 years old. 2. In accordance with the American Society of Anesthesiologists classification of grade ?-?. 3. Patients undergoing elective radical gastrectomy under general anesthesia. 4. Preoperative Mini-mental state examination (MMSE) score >=23. 5. Only cefuroxime sodium was used for perioperative antibiotic therapy. 6. Patients who were willing to receive electroacupuncture treatment and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with diseases affecting cognitive function assessment or unable to cooperate with cognitive function assessment. 2. Patients with a history of inflammatory bowel disease and irritable bowel. 3. Patients who had used antibiotics, probiotics, or received other gastrointestinal surgery within 3 months before admission. 4. Patients with a history of severe cardiovascular and cerebrovascular diseases and hepatic and renal insufficiency. 5. Serious adverse reactions or other complications occurred during the trial.

Design outcomes

Primary

MeasureTime frame
Mini-mental state examination score;Activity of Daily Living Scale;

Countries

China

Contacts

Public ContactTian Weiqian

Affiliated Hospital of Nanjing University of Chinese Medicine

yfy0066@njucm.edu.cn+86 25 8661 7141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026